August 6, 2026 LifeMine Raises $263 Million to Accelerate the Clinical Development of LIFE-001, a Structurally and Mechanistically Novel Calcineurin Activation Inhibitor Designed to Transform Organ Transplantation
August 6, 2026 Vontier Reports Strong Second Quarter Results and Raises Full Year Adjusted EPS Guidance
